The NIH Transplant and Cellular Therapy (TCT) Clinical Program is located in the NIH Clinical Center in Bethesda, Maryland. The Clinical Center is a 200-bed inpatient and outpatient hospital that cares for research participants of NIH physicians. It is the largest facility in the country devoted exclusively to clinical research. Every patient at NIH, including those receiving cell therapy, is treated on a clinical trial and all care is provided free of charge.
The NIH TCT Program transplants approximately 80 patients per year on clinical trials in the National Cancer Institute, National Heart Lung and Blood Institute, and the National Institute of Allergy and Infectious Disease. Our hematopoietic cellular therapy trials include allogeneic stem cell transplantation for malignant and non-malignant diseases, including inherited immune disorders and Sickle Cell Disease; gene therapy using autologous stem cells for nonmalignant disorders; and Chimeric Antigen Receptor T-cell therapy for both hematologic and solid malignancies. The NIH has programs focused on myeloid and lymphoid malignancies, a Graft-versus-Host Disease Program, and multiple long-term follow-up protocols that offer patients access to ongoing care and expertise in these fields.
NIH Clinical Studies Information Request: 800-411-1222
Search the Studies: https://clinicalstudies.info.nih.gov/
For more information contact jennifer.wilder@nih.gov
Note:
The mention of the NIH collaboration is not to be construed as an actual or implied endorsement by the United States government of the mentioned products, their use, or the associated organization. The content of this event does not necessarily reflect the views, policies, or opinions of the NIH. The mention of commercial products, their source, or their use in connection with material reported herein is not to be construed as an actual or implied endorsement of such products by NIH. Opinions expressed within the symposium presentations or website are not necessarily those of the NIH.